Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.23.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Series B1 Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Series B1 Preferred Stock
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common Stock, Beginning Balance (in shares) at Dec. 31, 2021 [1]     6,078,467        
Beginning Balance at Dec. 31, 2021 $ 85,004   $ 5 $ 198,179   $ (112,811) $ (369)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Legacy Shapways common stock upon exercise of stock options, (in shares) [1]     27,246        
Issuance of common stock for stock-based compensation 99     99      
Stock-based compensation expense 312     312      
Net loss (4,037)         (4,037)  
Transfer of Private Warrants to Public Warrants 382     382      
Foreign currency translation adjustment (52)           (52)
Ending Balance at Mar. 31, 2022 81,708   $ 5 198,972   (116,848) (421)
Common Stock, Ending Balance (in shares) at Mar. 31, 2022 [1]     6,105,713        
Common Stock, Beginning Balance (in shares) at Dec. 31, 2021 [1]     6,078,467        
Beginning Balance at Dec. 31, 2021 85,004   $ 5 198,179   (112,811) (369)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (8,711)            
Foreign currency translation adjustment (226)            
Ending Balance at Jun. 30, 2022 77,794   $ 5 199,906   (121,522) (595)
Common Stock, Ending Balance (in shares) at Jun. 30, 2022 [1]     6,151,679        
Common Stock, Beginning Balance (in shares) at Mar. 31, 2022 [1]     6,105,713        
Beginning Balance at Mar. 31, 2022 81,708   $ 5 198,972   (116,848) (421)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Legacy Shapways common stock upon exercise of stock options, (in shares) [1]     45,966        
Issuance of common stock for stock-based compensation 189     189      
Stock-based compensation expense   $ 457     $ 457    
Net loss (4,674)         (4,674)  
Transfer of Private Warrants to Public Warrants 288     288      
Foreign currency translation adjustment (174)           (174)
Ending Balance at Jun. 30, 2022 $ 77,794   $ 5 199,906   (121,522) (595)
Common Stock, Ending Balance (in shares) at Jun. 30, 2022 [1]     6,151,679        
Common Stock, Beginning Balance (in shares) at Dec. 31, 2022 6,180,646   6,180,646 [1]        
Beginning Balance at Dec. 31, 2022 $ 67,791   $ 5 201,362   (133,032) (544)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Legacy Shapways common stock upon exercise of stock options, (in shares) 32   20,507 [1]        
Cancellation of restricted stock (in shares) [1]     (7)        
Stock-based compensation expense $ 805     805      
Net loss (7,403)         (7,403)  
Foreign currency translation adjustment 39           39
Ending Balance at Mar. 31, 2023 $ 61,232   $ 5 202,167   (140,435) (505)
Common Stock, Ending Balance (in shares) at Mar. 31, 2023 [1]     6,201,146        
Common Stock, Beginning Balance (in shares) at Dec. 31, 2022 6,180,646   6,180,646 [1]        
Beginning Balance at Dec. 31, 2022 $ 67,791   $ 5 201,362   (133,032) (544)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (14,184)            
Foreign currency translation adjustment 44            
Ending Balance at Jun. 30, 2023 $ 55,354   $ 5 203,065   (147,216) (500)
Common Stock, Ending Balance (in shares) at Jun. 30, 2023 6,442,436   6,442,436 [1]        
Common Stock, Beginning Balance (in shares) at Mar. 31, 2023 [1]     6,201,146        
Beginning Balance at Mar. 31, 2023 $ 61,232   $ 5 202,167   (140,435) (505)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Legacy Shapways common stock upon exercise of stock options, (in shares) 0   118,945 [1]        
Issuance of common stock upon settlement of earnout consideration liability (shares) [1]     156,658        
Issuance of common stock upon settlement of earnout consideration liability $ 537     537      
Restricted stock units withheld for employee tax liability (shares) [1] (34,058)            
Restricted stock units withheld for employee tax liability $ (111)     (111)      
Cancellation of restricted stock (in shares) [1]     (170)        
Stock-based compensation expense 476     476      
Settlement of fractional shares on reverse stock split, (shares) [1]     (85)        
Redemption of fractional shares on reverse stock split (4)     (4)      
Net loss (6,781)         (6,781)  
Foreign currency translation adjustment 5           5
Ending Balance at Jun. 30, 2023 $ 55,354   $ 5 $ 203,065   $ (147,216) $ (500)
Common Stock, Ending Balance (in shares) at Jun. 30, 2023 6,442,436   6,442,436 [1]        
[1] Retroactively adjusted shares issued and outstanding to give effect to the Company's 1-for-8 reverse stock split. See Note 2.